Clinical Trials Logo

Clinical Trial Summary

Branch atheromatous disease (BAD) has been reported to contribute to small-vessel occlusion and is associated with a higher possibility of early neurological deterioration (END). Because the pathology of BAD is due to atherosclerosis, the investigators postulate that early intensive medical treatment with dual antiplatelet therapy(DAPT) and high-intensity statin may prevent END and recurrent stroke. The investigators hypothesise that intensive medical therapy can prevent END in BAD using aspirin, clopidogrel and high-intensity statin.

Clinical Trial Description

The SATBRAD study is a single-centre, prospective, open-label, single-group trial with a historical control group of BAD patients treated with single antiplatelet therapy and regular statin treatment in Chang Gung Memorial Hospital in Taiwan. Eligible participants are as follows: 1. have a clinical diagnosis of ischemic stroke; 2. National Institute of Health Stroke Scale (NIHSS) score of 1-8; 3. an ischemic lesion on diffuse-weighted imaging located in the middle cerebral artery(MCA) perforator, Heubner's artery or vertebrobasilar perforator territories; 4. BAD, defined by a visible lesion in three or more axial MRI cuts in the MCA perforator territory or Heubner's artery territories or infarcts that extended from the basal surface of the brainstem. 5. can receive intensive medical treatment within 24 hours of stroke onset. Participants in the intervention group will receive DAPT and high-intensity statin treatment. DAPT treatment is administered within 24 hours of stroke onset, with aspirin (300 mg loading and 100 mg/day) and clopidogrel (300mg and 75m/day). Participants will take aspirin and clopidogrel for 21 days and then keep aspirin or clopidogrel alone. High-intensity statin is administered, including atorvastatin 40-80mg or rosuvastatin 20 mg for 3 months. A historical control group of patients receiving single oral antiplatelet medication and regular statin treatment will be drawn from previous prospective observation studies which were executed since Jan. 2011 to Dec. 2020. The total sample sizes are 147 for intervention group and 277 for control group. The primary endpoint is the composite of END, defined as an increase of ≧2 points of NIHSS within 7 days, and recurrent ischemic stroke within 30 days. ;

Study Design

Related Conditions & MeSH terms

NCT number NCT04824911
Study type Interventional
Source Chang Gung Memorial Hospital
Contact Yenchu Huang
Phone +88653625642
Email [email protected]
Status Recruiting
Phase Phase 2
Start date March 23, 2021
Completion date July 30, 2026

See also
  Status Clinical Trial Phase
Recruiting NCT03281590 - Stroke and Cerebrovascular Diseases Registry
Terminated NCT04039178 - Efficacy of EMF BCI Based Device on Acute Stroke N/A
Recruiting NCT04521634 - Glycaemic Variability in Acute Stroke
Completed NCT03477188 - The Effects of Somatosensory and Vestibular Rehabilitation Additional Conventional Therapy on Balance in Patients With Acute Stroke. N/A
Recruiting NCT02677415 - Impact of Anesthesia Type on Outcome in Patients With Acute Ischemic Stroke (AIS) Undergoing Endovascular Treatment N/A
Recruiting NCT01541163 - Heart and Ischemic STrOke Relationship studY N/A
Completed NCT01210729 - Mechanical Recanalization With Flow Restoration in Acute Ischemic Stroke Phase 2
Recruiting NCT00785343 - Study of Robot-assisted Arm Therapy for Acute Stroke Patients Phase 1
Completed NCT04779710 - How Does Dysphagia Assessment in Acute Stroke Affect Pneumonia?
Recruiting NCT03635749 - Intensive Medical Therapy for High-risk Intracranial or Extracranial Arterial Stenosis Phase 3
Recruiting NCT04491695 - Tirofiban for the Prevention of Neurological Deterioration in Acute Ischemic Stroke Phase 2/Phase 3
Recruiting NCT04283760 - Investigation of the Reliability and Validity of the Movement Imagination Questionnaire - Revised Second in Acute Stroke Patients
Recruiting NCT04214522 - Reliability and Validity of the Kinesthetic and Visual Imagery Questionnaire in Acute Stroke Patients
Recruiting NCT04734548 - Phase Ib/IIa Clinical Study of ApTOLL for the Treatment of Acute Ischemic Stroke Phase 1/Phase 2
Enrolling by invitation NCT04437862 - A Study to Evaluate the Q Revascularization System for Neurointervention in Acute Ischemic Stroke N/A
Completed NCT02720276 - Sms Guided Training After Acute Stroke N/A
Completed NCT03036020 - The Norwegian Acute Stroke Prehospital Project N/A
Completed NCT01501773 - Intravenous Autologous Bone Marrow-derived Stem Cells Therapy for Patients With Acute Ischemic Stroke Phase 2
Terminated NCT00331890 - ICTUS Study: International Citicoline Trial on Acute Stroke Phase 3
Recruiting NCT03737786 - SEACOAST 1- SEdAtion With COllAteral Support in Endovascular Therapy for Acute Ischemic Stroke N/A